MoCA: Screening for Mild Cognitive Impairment
The MoCA is a 30 point cognitive screening test built to detect mild cognitive impairment, where briefer screens tend to miss it.
Montreal Cognitive Assessment (MoCA)
The Montreal Cognitive Assessment is a one page, 30 point screening test covering visuospatial and executive function, naming, memory, attention, language, abstraction and orientation. It was designed specifically to detect mild cognitive impairment, a range in which the Mini-Mental State Examination performs poorly.
Category
Disease
Source
What is the Montreal Cognitive Assessment
The Montreal Cognitive Assessment covers seven cognitive domains in about ten minutes: visuospatial and executive function through a trail making task, cube copy and clock drawing; naming; memory through delayed recall of five words; attention through digit span, vigilance and serial subtraction; language through repetition and verbal fluency; abstraction; and orientation.
It was developed to fill a specific gap. Brief global screens are reasonably sensitive to established dementia and insensitive to mild cognitive impairment, largely because they under-sample executive function and delayed recall. The MoCA weights both more heavily, which is why it detects impairment that shorter screens miss and why it is harder for people with intact cognition to score full marks.
Scores run from zero to 30. A cut-off of 26 was proposed in the original validation, with one point added for people with 12 years of education or fewer. Later work has repeatedly found that a single cut-off does not transfer across populations: education, first language and cultural familiarity with the test material all shift scores, and applying an imported threshold will misclassify people.
Two practical points. The MoCA requires training and, since 2020, certification to administer, and use is controlled by the copyright holder. Multiple alternate forms exist and should be rotated in longitudinal studies, because repeating the same version produces a practice effect that can mask real decline.
Advantages
Enables precise identification of patient health status.
.svg){kind=icon}
Identifies health issues during initial stages.
.svg){kind=icon}
Allow for comparisons between different groups.
.svg){kind=icon}
Strengthens evidence through systematic measurement approaches.
.png){kind=icon}
Related Instruments
Digital counterpart
Digital biomarkers that measure the same thing with sensors rather than a questionnaire.
Collect MoCA data with WeGuide, the all in one patient engagement platform
.jpg)
Support Your patient in no time - all under your own brand
Our platform combines the knowledge of 100+ digital health solutions built, letting you easily build your patient engagement app for research or clinical use. Collect PROMs, support patients on waiting lists, or gather vital signs data. This is how:
Learn More.png){kind=icon}
Program Builder
.png)
.png){kind=icon}
Whitelabelling
.svg)
.svg)
.png){kind=icon}
Turn on components, dependent on your usecase
.svg)
.png){kind=icon}
Support The Full Journey
.png)
.png)
%20(1).png)
.png)
It’s your turn
Every WeGuide project, saves researchers and clinicians - 9 months and $450,000 - creating impactful digital health solutions.
